SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-058228
Filing Date
2023-11-02
Accepted
2023-11-02 16:15:42
Documents
86
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mirm-20230930.htm   iXBRL 10-Q 3617707
2 EX-5.1 mirm-ex5_1.htm EX-5.1 20482
3 EX-10.3 mirm-ex10_3.htm EX-10.3 398928
4 EX-31.1 mirm-ex31_1.htm EX-31.1 18663
5 EX-31.2 mirm-ex31_2.htm EX-31.2 18612
6 EX-32.1 mirm-ex32_1.htm EX-32.1 10503
7 EX-32.2 mirm-ex32_2.htm EX-32.2 10483
  Complete submission text file 0000950170-23-058228.txt   14304213

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mirm-20230930_pre.xml EX-101.PRE 545494
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mirm-20230930.xsd EX-101.SCH 92283
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mirm-20230930_def.xml EX-101.DEF 365457
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mirm-20230930_cal.xml EX-101.CAL 70777
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mirm-20230930_lab.xml EX-101.LAB 704992
80 EXTRACTED XBRL INSTANCE DOCUMENT mirm-20230930_htm.xml XML 2672331
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38981 | Film No.: 231372514
SIC: 2834 Pharmaceutical Preparations